nodes	percent_of_prediction	percent_of_DWPC	metapath
Theophylline—CYP1B1—Tamoxifen—pancreatic cancer	0.0844	0.116	CbGbCtD
Theophylline—CYP1B1—Erlotinib—pancreatic cancer	0.0718	0.0984	CbGbCtD
Theophylline—SLC22A7—Fluorouracil—pancreatic cancer	0.0563	0.0771	CbGbCtD
Theophylline—CYP1B1—Docetaxel—pancreatic cancer	0.0475	0.0651	CbGbCtD
Theophylline—CYP1A1—Dacarbazine—pancreatic cancer	0.0466	0.0638	CbGbCtD
Theophylline—SLC22A7—Docetaxel—pancreatic cancer	0.043	0.0589	CbGbCtD
Theophylline—CYP1A1—Tamoxifen—pancreatic cancer	0.037	0.0508	CbGbCtD
Theophylline—CYP2E1—Dacarbazine—pancreatic cancer	0.036	0.0493	CbGbCtD
Theophylline—CYP1B1—Doxorubicin—pancreatic cancer	0.0354	0.0485	CbGbCtD
Theophylline—CYP1A1—Erlotinib—pancreatic cancer	0.0315	0.0432	CbGbCtD
Theophylline—CYP2E1—Tamoxifen—pancreatic cancer	0.0286	0.0392	CbGbCtD
Theophylline—CYP2C8—Tamoxifen—pancreatic cancer	0.0214	0.0293	CbGbCtD
Theophylline—CYP1A2—Dacarbazine—pancreatic cancer	0.0208	0.0285	CbGbCtD
Theophylline—CYP2C8—Erlotinib—pancreatic cancer	0.0182	0.0249	CbGbCtD
Theophylline—CYP1A2—Tamoxifen—pancreatic cancer	0.0166	0.0227	CbGbCtD
Theophylline—CYP2C8—Fluorouracil—pancreatic cancer	0.0158	0.0216	CbGbCtD
Theophylline—CYP2C9—Tamoxifen—pancreatic cancer	0.0149	0.0204	CbGbCtD
Theophylline—CYP1A2—Erlotinib—pancreatic cancer	0.0141	0.0193	CbGbCtD
Theophylline—CYP2D6—Tamoxifen—pancreatic cancer	0.0136	0.0187	CbGbCtD
Theophylline—CYP1A2—Fluorouracil—pancreatic cancer	0.0122	0.0167	CbGbCtD
Theophylline—CYP2D6—Erlotinib—pancreatic cancer	0.0116	0.0159	CbGbCtD
Theophylline—CYP2C9—Fluorouracil—pancreatic cancer	0.011	0.0151	CbGbCtD
Theophylline—CYP3A4—Tamoxifen—pancreatic cancer	0.00867	0.0119	CbGbCtD
Theophylline—CYP3A4—Erlotinib—pancreatic cancer	0.00737	0.0101	CbGbCtD
Theophylline—CYP3A4—Irinotecan—pancreatic cancer	0.00666	0.00912	CbGbCtD
Theophylline—CYP2D6—Doxorubicin—pancreatic cancer	0.00572	0.00784	CbGbCtD
Theophylline—CYP3A4—Docetaxel—pancreatic cancer	0.00488	0.00668	CbGbCtD
Theophylline—CYP3A4—Sunitinib—pancreatic cancer	0.00486	0.00665	CbGbCtD
Theophylline—CYP3A4—Doxorubicin—pancreatic cancer	0.00364	0.00498	CbGbCtD
Theophylline—Caffeine—PIK3CB—pancreatic cancer	0.0026	0.361	CrCbGaD
Theophylline—Caffeine—PIK3CD—pancreatic cancer	0.0026	0.361	CrCbGaD
Theophylline—HDAC2—Topotecan—Irinotecan—pancreatic cancer	0.00255	0.598	CbGdCrCtD
Theophylline—Caffeine—PIK3CA—pancreatic cancer	0.00201	0.279	CrCbGaD
Theophylline—HDAC2—Gefitinib—Erlotinib—pancreatic cancer	0.00172	0.402	CbGdCrCtD
Theophylline—Hypokalaemia—Irinotecan—pancreatic cancer	0.000547	0.00571	CcSEcCtD
Theophylline—Flushing—Tamoxifen—pancreatic cancer	0.000547	0.00571	CcSEcCtD
Theophylline—Hypokalaemia—Gemcitabine—pancreatic cancer	0.000533	0.00556	CcSEcCtD
Theophylline—Arrhythmia—Tamoxifen—pancreatic cancer	0.000527	0.0055	CcSEcCtD
Theophylline—Ventricular arrhythmia—Epirubicin—pancreatic cancer	0.000522	0.00544	CcSEcCtD
Theophylline—Arrhythmia—Erlotinib—pancreatic cancer	0.000521	0.00544	CcSEcCtD
Theophylline—Alopecia—Tamoxifen—pancreatic cancer	0.000521	0.00544	CcSEcCtD
Theophylline—Albuminuria—Epirubicin—pancreatic cancer	0.000517	0.0054	CcSEcCtD
Theophylline—Alopecia—Erlotinib—pancreatic cancer	0.000516	0.00538	CcSEcCtD
Theophylline—Hypercalcaemia—Doxorubicin—pancreatic cancer	0.000514	0.00537	CcSEcCtD
Theophylline—Haematemesis—Doxorubicin—pancreatic cancer	0.000514	0.00537	CcSEcCtD
Theophylline—Ventricular arrhythmia—Doxorubicin—pancreatic cancer	0.000483	0.00504	CcSEcCtD
Theophylline—Phlebitis—Docetaxel—pancreatic cancer	0.000482	0.00503	CcSEcCtD
Theophylline—Albuminuria—Doxorubicin—pancreatic cancer	0.000479	0.00499	CcSEcCtD
Theophylline—Flushing—Sunitinib—pancreatic cancer	0.000469	0.00489	CcSEcCtD
Theophylline—Hyperglycaemia—Gemcitabine—pancreatic cancer	0.000457	0.00476	CcSEcCtD
Theophylline—Arrhythmia—Sunitinib—pancreatic cancer	0.000451	0.00471	CcSEcCtD
Theophylline—Alopecia—Sunitinib—pancreatic cancer	0.000446	0.00466	CcSEcCtD
Theophylline—Extravasation—Epirubicin—pancreatic cancer	0.000443	0.00462	CcSEcCtD
Theophylline—Atrial fibrillation—Docetaxel—pancreatic cancer	0.000439	0.00458	CcSEcCtD
Theophylline—Anxiety—Tamoxifen—pancreatic cancer	0.000435	0.00454	CcSEcCtD
Theophylline—Anxiety—Erlotinib—pancreatic cancer	0.000431	0.0045	CcSEcCtD
Theophylline—Haematuria—Gemcitabine—pancreatic cancer	0.00043	0.00449	CcSEcCtD
Theophylline—Ventricular extrasystoles—Epirubicin—pancreatic cancer	0.000428	0.00446	CcSEcCtD
Theophylline—Hyperuricaemia—Epirubicin—pancreatic cancer	0.000416	0.00434	CcSEcCtD
Theophylline—Infection—Tamoxifen—pancreatic cancer	0.000416	0.00434	CcSEcCtD
Theophylline—Infection—Erlotinib—pancreatic cancer	0.000412	0.0043	CcSEcCtD
Theophylline—Extravasation—Doxorubicin—pancreatic cancer	0.00041	0.00427	CcSEcCtD
Theophylline—Shock—Erlotinib—pancreatic cancer	0.000408	0.00425	CcSEcCtD
Theophylline—Nervous system disorder—Erlotinib—pancreatic cancer	0.000406	0.00424	CcSEcCtD
Theophylline—Anorexia—Tamoxifen—pancreatic cancer	0.000399	0.00417	CcSEcCtD
Theophylline—Ventricular extrasystoles—Doxorubicin—pancreatic cancer	0.000396	0.00413	CcSEcCtD
Theophylline—Anorexia—Erlotinib—pancreatic cancer	0.000395	0.00412	CcSEcCtD
Theophylline—Blood uric acid increased—Epirubicin—pancreatic cancer	0.000393	0.0041	CcSEcCtD
Theophylline—Flushing—Irinotecan—pancreatic cancer	0.000386	0.00403	CcSEcCtD
Theophylline—Hyperuricaemia—Doxorubicin—pancreatic cancer	0.000385	0.00402	CcSEcCtD
Theophylline—Dermatitis contact—Epirubicin—pancreatic cancer	0.000382	0.00398	CcSEcCtD
Theophylline—Convulsion—Sunitinib—pancreatic cancer	0.000381	0.00397	CcSEcCtD
Theophylline—Abdominal pain upper—Docetaxel—pancreatic cancer	0.00038	0.00396	CcSEcCtD
Theophylline—Insomnia—Tamoxifen—pancreatic cancer	0.000379	0.00395	CcSEcCtD
Theophylline—Insomnia—Erlotinib—pancreatic cancer	0.000375	0.00391	CcSEcCtD
Theophylline—Arrhythmia—Irinotecan—pancreatic cancer	0.000372	0.00388	CcSEcCtD
Theophylline—Alopecia—Irinotecan—pancreatic cancer	0.000368	0.00384	CcSEcCtD
Theophylline—Decreased appetite—Tamoxifen—pancreatic cancer	0.000364	0.0038	CcSEcCtD
Theophylline—Blood uric acid increased—Doxorubicin—pancreatic cancer	0.000364	0.0038	CcSEcCtD
Theophylline—Arrhythmia—Gemcitabine—pancreatic cancer	0.000362	0.00378	CcSEcCtD
Theophylline—Decreased appetite—Erlotinib—pancreatic cancer	0.00036	0.00376	CcSEcCtD
Theophylline—Alopecia—Gemcitabine—pancreatic cancer	0.000358	0.00374	CcSEcCtD
Theophylline—Infection—Sunitinib—pancreatic cancer	0.000356	0.00372	CcSEcCtD
Theophylline—Arrhythmia—Fluorouracil—pancreatic cancer	0.000356	0.00371	CcSEcCtD
Theophylline—Dermatitis contact—Doxorubicin—pancreatic cancer	0.000353	0.00368	CcSEcCtD
Theophylline—Shock—Sunitinib—pancreatic cancer	0.000353	0.00368	CcSEcCtD
Theophylline—Coma—Epirubicin—pancreatic cancer	0.000353	0.00368	CcSEcCtD
Theophylline—Alopecia—Fluorouracil—pancreatic cancer	0.000352	0.00367	CcSEcCtD
Theophylline—Nervous system disorder—Sunitinib—pancreatic cancer	0.000352	0.00367	CcSEcCtD
Theophylline—Gastrointestinal pain—Tamoxifen—pancreatic cancer	0.000343	0.00357	CcSEcCtD
Theophylline—Anorexia—Sunitinib—pancreatic cancer	0.000342	0.00357	CcSEcCtD
Theophylline—Gastrointestinal pain—Erlotinib—pancreatic cancer	0.000339	0.00354	CcSEcCtD
Theophylline—Urticaria—Tamoxifen—pancreatic cancer	0.000333	0.00347	CcSEcCtD
Theophylline—Abdominal pain—Tamoxifen—pancreatic cancer	0.000331	0.00345	CcSEcCtD
Theophylline—Abdominal pain—Erlotinib—pancreatic cancer	0.000328	0.00342	CcSEcCtD
Theophylline—Body temperature increased—Erlotinib—pancreatic cancer	0.000328	0.00342	CcSEcCtD
Theophylline—Coma—Doxorubicin—pancreatic cancer	0.000327	0.00341	CcSEcCtD
Theophylline—Phlebitis—Epirubicin—pancreatic cancer	0.000325	0.0034	CcSEcCtD
Theophylline—Insomnia—Sunitinib—pancreatic cancer	0.000325	0.00339	CcSEcCtD
Theophylline—Decreased appetite—Sunitinib—pancreatic cancer	0.000312	0.00325	CcSEcCtD
Theophylline—Hypersensitivity—Tamoxifen—pancreatic cancer	0.000309	0.00322	CcSEcCtD
Theophylline—Phlebitis—Doxorubicin—pancreatic cancer	0.000301	0.00314	CcSEcCtD
Theophylline—Convulsion—Fluorouracil—pancreatic cancer	0.0003	0.00314	CcSEcCtD
Theophylline—Dermatitis exfoliative—Epirubicin—pancreatic cancer	0.000297	0.0031	CcSEcCtD
Theophylline—Pruritus—Tamoxifen—pancreatic cancer	0.000296	0.00309	CcSEcCtD
Theophylline—Anaphylactic shock—Irinotecan—pancreatic cancer	0.000296	0.00308	CcSEcCtD
Theophylline—Infection—Irinotecan—pancreatic cancer	0.000294	0.00306	CcSEcCtD
Theophylline—Gastrointestinal pain—Sunitinib—pancreatic cancer	0.000293	0.00306	CcSEcCtD
Theophylline—Pruritus—Erlotinib—pancreatic cancer	0.000293	0.00306	CcSEcCtD
Theophylline—Shock—Irinotecan—pancreatic cancer	0.000291	0.00303	CcSEcCtD
Theophylline—Nervous system disorder—Irinotecan—pancreatic cancer	0.00029	0.00302	CcSEcCtD
Theophylline—Anaphylactoid reaction—Epirubicin—pancreatic cancer	0.00029	0.00302	CcSEcCtD
Theophylline—Anaphylactic shock—Gemcitabine—pancreatic cancer	0.000288	0.003	CcSEcCtD
Theophylline—Diarrhoea—Tamoxifen—pancreatic cancer	0.000287	0.00299	CcSEcCtD
Theophylline—Infection—Gemcitabine—pancreatic cancer	0.000286	0.00298	CcSEcCtD
Theophylline—Abdominal pain—Sunitinib—pancreatic cancer	0.000284	0.00296	CcSEcCtD
Theophylline—Body temperature increased—Sunitinib—pancreatic cancer	0.000284	0.00296	CcSEcCtD
Theophylline—Diarrhoea—Erlotinib—pancreatic cancer	0.000284	0.00296	CcSEcCtD
Theophylline—Anaphylactic shock—Fluorouracil—pancreatic cancer	0.000283	0.00295	CcSEcCtD
Theophylline—Nervous system disorder—Gemcitabine—pancreatic cancer	0.000282	0.00295	CcSEcCtD
Theophylline—Anorexia—Irinotecan—pancreatic cancer	0.000282	0.00294	CcSEcCtD
Theophylline—Infection—Fluorouracil—pancreatic cancer	0.000281	0.00293	CcSEcCtD
Theophylline—Nervous system disorder—Fluorouracil—pancreatic cancer	0.000278	0.0029	CcSEcCtD
Theophylline—Dizziness—Tamoxifen—pancreatic cancer	0.000277	0.00289	CcSEcCtD
Theophylline—Tachycardia—Fluorouracil—pancreatic cancer	0.000276	0.00288	CcSEcCtD
Theophylline—Hypotension—Irinotecan—pancreatic cancer	0.000276	0.00288	CcSEcCtD
Theophylline—Dermatitis exfoliative—Doxorubicin—pancreatic cancer	0.000275	0.00287	CcSEcCtD
Theophylline—Anorexia—Gemcitabine—pancreatic cancer	0.000274	0.00286	CcSEcCtD
Theophylline—Dizziness—Erlotinib—pancreatic cancer	0.000274	0.00286	CcSEcCtD
Theophylline—Anorexia—Fluorouracil—pancreatic cancer	0.00027	0.00282	CcSEcCtD
Theophylline—Hypotension—Gemcitabine—pancreatic cancer	0.000269	0.00281	CcSEcCtD
Theophylline—Anaphylactoid reaction—Doxorubicin—pancreatic cancer	0.000268	0.0028	CcSEcCtD
Theophylline—Insomnia—Irinotecan—pancreatic cancer	0.000267	0.00279	CcSEcCtD
Theophylline—Flushing—Docetaxel—pancreatic cancer	0.000267	0.00278	CcSEcCtD
Theophylline—Vomiting—Tamoxifen—pancreatic cancer	0.000266	0.00278	CcSEcCtD
Theophylline—Hypotension—Fluorouracil—pancreatic cancer	0.000264	0.00276	CcSEcCtD
Theophylline—Hypersensitivity—Sunitinib—pancreatic cancer	0.000264	0.00276	CcSEcCtD
Theophylline—Rash—Tamoxifen—pancreatic cancer	0.000264	0.00276	CcSEcCtD
Theophylline—Dermatitis—Tamoxifen—pancreatic cancer	0.000264	0.00275	CcSEcCtD
Theophylline—Vomiting—Erlotinib—pancreatic cancer	0.000264	0.00275	CcSEcCtD
Theophylline—Headache—Tamoxifen—pancreatic cancer	0.000262	0.00274	CcSEcCtD
Theophylline—Rash—Erlotinib—pancreatic cancer	0.000261	0.00273	CcSEcCtD
Theophylline—Dermatitis—Erlotinib—pancreatic cancer	0.000261	0.00272	CcSEcCtD
Theophylline—Insomnia—Gemcitabine—pancreatic cancer	0.00026	0.00272	CcSEcCtD
Theophylline—Headache—Erlotinib—pancreatic cancer	0.00026	0.00271	CcSEcCtD
Theophylline—Decreased appetite—Irinotecan—pancreatic cancer	0.000257	0.00268	CcSEcCtD
Theophylline—Arrhythmia—Docetaxel—pancreatic cancer	0.000257	0.00268	CcSEcCtD
Theophylline—Abdominal pain upper—Epirubicin—pancreatic cancer	0.000256	0.00267	CcSEcCtD
Theophylline—Insomnia—Fluorouracil—pancreatic cancer	0.000256	0.00267	CcSEcCtD
Theophylline—Hypokalaemia—Epirubicin—pancreatic cancer	0.000255	0.00266	CcSEcCtD
Theophylline—Alopecia—Docetaxel—pancreatic cancer	0.000254	0.00265	CcSEcCtD
Theophylline—Pruritus—Sunitinib—pancreatic cancer	0.000254	0.00265	CcSEcCtD
Theophylline—Decreased appetite—Gemcitabine—pancreatic cancer	0.00025	0.00261	CcSEcCtD
Theophylline—Nausea—Tamoxifen—pancreatic cancer	0.000249	0.0026	CcSEcCtD
Theophylline—Nausea—Erlotinib—pancreatic cancer	0.000246	0.00257	CcSEcCtD
Theophylline—Decreased appetite—Fluorouracil—pancreatic cancer	0.000246	0.00257	CcSEcCtD
Theophylline—Diarrhoea—Sunitinib—pancreatic cancer	0.000245	0.00256	CcSEcCtD
Theophylline—Gastrointestinal pain—Irinotecan—pancreatic cancer	0.000242	0.00252	CcSEcCtD
Theophylline—Dizziness—Sunitinib—pancreatic cancer	0.000237	0.00248	CcSEcCtD
Theophylline—Abdominal pain upper—Doxorubicin—pancreatic cancer	0.000237	0.00247	CcSEcCtD
Theophylline—Hypokalaemia—Doxorubicin—pancreatic cancer	0.000236	0.00246	CcSEcCtD
Theophylline—Abdominal pain—Irinotecan—pancreatic cancer	0.000234	0.00244	CcSEcCtD
Theophylline—Body temperature increased—Irinotecan—pancreatic cancer	0.000234	0.00244	CcSEcCtD
Theophylline—Vomiting—Sunitinib—pancreatic cancer	0.000228	0.00238	CcSEcCtD
Theophylline—Body temperature increased—Gemcitabine—pancreatic cancer	0.000228	0.00237	CcSEcCtD
Theophylline—Rash—Sunitinib—pancreatic cancer	0.000226	0.00236	CcSEcCtD
Theophylline—Dermatitis—Sunitinib—pancreatic cancer	0.000226	0.00236	CcSEcCtD
Theophylline—Urticaria—Fluorouracil—pancreatic cancer	0.000225	0.00235	CcSEcCtD
Theophylline—Headache—Sunitinib—pancreatic cancer	0.000225	0.00235	CcSEcCtD
Theophylline—Body temperature increased—Fluorouracil—pancreatic cancer	0.000224	0.00233	CcSEcCtD
Theophylline—Palpitations—Docetaxel—pancreatic cancer	0.000221	0.00231	CcSEcCtD
Theophylline—Hyperglycaemia—Epirubicin—pancreatic cancer	0.000219	0.00228	CcSEcCtD
Theophylline—Hypersensitivity—Irinotecan—pancreatic cancer	0.000218	0.00227	CcSEcCtD
Theophylline—Convulsion—Docetaxel—pancreatic cancer	0.000217	0.00226	CcSEcCtD
Theophylline—Nausea—Sunitinib—pancreatic cancer	0.000213	0.00222	CcSEcCtD
Theophylline—Hypersensitivity—Fluorouracil—pancreatic cancer	0.000209	0.00218	CcSEcCtD
Theophylline—Haematuria—Epirubicin—pancreatic cancer	0.000206	0.00215	CcSEcCtD
Theophylline—Anaphylactic shock—Docetaxel—pancreatic cancer	0.000204	0.00213	CcSEcCtD
Theophylline—Pruritus—Gemcitabine—pancreatic cancer	0.000204	0.00213	CcSEcCtD
Theophylline—Infection—Docetaxel—pancreatic cancer	0.000203	0.00212	CcSEcCtD
Theophylline—Hyperglycaemia—Doxorubicin—pancreatic cancer	0.000202	0.00211	CcSEcCtD
Theophylline—Diarrhoea—Irinotecan—pancreatic cancer	0.000202	0.00211	CcSEcCtD
Theophylline—Shock—Docetaxel—pancreatic cancer	0.000201	0.0021	CcSEcCtD
Theophylline—Nervous system disorder—Docetaxel—pancreatic cancer	0.0002	0.00209	CcSEcCtD
Theophylline—Pruritus—Fluorouracil—pancreatic cancer	0.0002	0.00209	CcSEcCtD
Theophylline—Tachycardia—Docetaxel—pancreatic cancer	0.000199	0.00208	CcSEcCtD
Theophylline—Diarrhoea—Gemcitabine—pancreatic cancer	0.000197	0.00206	CcSEcCtD
Theophylline—Dizziness—Irinotecan—pancreatic cancer	0.000195	0.00204	CcSEcCtD
Theophylline—Anorexia—Docetaxel—pancreatic cancer	0.000195	0.00203	CcSEcCtD
Theophylline—Diarrhoea—Fluorouracil—pancreatic cancer	0.000194	0.00202	CcSEcCtD
Theophylline—Hypotension—Docetaxel—pancreatic cancer	0.000191	0.00199	CcSEcCtD
Theophylline—Haematuria—Doxorubicin—pancreatic cancer	0.000191	0.00199	CcSEcCtD
Theophylline—Vomiting—Irinotecan—pancreatic cancer	0.000188	0.00196	CcSEcCtD
Theophylline—Dizziness—Fluorouracil—pancreatic cancer	0.000187	0.00195	CcSEcCtD
Theophylline—Rash—Irinotecan—pancreatic cancer	0.000186	0.00194	CcSEcCtD
Theophylline—Dermatitis—Irinotecan—pancreatic cancer	0.000186	0.00194	CcSEcCtD
Theophylline—Headache—Irinotecan—pancreatic cancer	0.000185	0.00193	CcSEcCtD
Theophylline—Insomnia—Docetaxel—pancreatic cancer	0.000185	0.00193	CcSEcCtD
Theophylline—Vomiting—Gemcitabine—pancreatic cancer	0.000183	0.00191	CcSEcCtD
Theophylline—Rash—Gemcitabine—pancreatic cancer	0.000182	0.00189	CcSEcCtD
Theophylline—Dermatitis—Gemcitabine—pancreatic cancer	0.000181	0.00189	CcSEcCtD
Theophylline—Headache—Gemcitabine—pancreatic cancer	0.00018	0.00188	CcSEcCtD
Theophylline—Flushing—Epirubicin—pancreatic cancer	0.00018	0.00188	CcSEcCtD
Theophylline—Vomiting—Fluorouracil—pancreatic cancer	0.00018	0.00188	CcSEcCtD
Theophylline—Rash—Fluorouracil—pancreatic cancer	0.000178	0.00186	CcSEcCtD
Theophylline—Dermatitis—Fluorouracil—pancreatic cancer	0.000178	0.00186	CcSEcCtD
Theophylline—Decreased appetite—Docetaxel—pancreatic cancer	0.000178	0.00185	CcSEcCtD
Theophylline—Headache—Fluorouracil—pancreatic cancer	0.000177	0.00185	CcSEcCtD
Theophylline—Nausea—Irinotecan—pancreatic cancer	0.000176	0.00183	CcSEcCtD
Theophylline—Arrhythmia—Epirubicin—pancreatic cancer	0.000173	0.00181	CcSEcCtD
Theophylline—Alopecia—Epirubicin—pancreatic cancer	0.000171	0.00179	CcSEcCtD
Theophylline—Nausea—Gemcitabine—pancreatic cancer	0.000171	0.00178	CcSEcCtD
Theophylline—Nausea—Fluorouracil—pancreatic cancer	0.000168	0.00175	CcSEcCtD
Theophylline—Gastrointestinal pain—Docetaxel—pancreatic cancer	0.000167	0.00174	CcSEcCtD
Theophylline—Flushing—Doxorubicin—pancreatic cancer	0.000167	0.00174	CcSEcCtD
Theophylline—Tension—Epirubicin—pancreatic cancer	0.000166	0.00173	CcSEcCtD
Theophylline—Nervousness—Epirubicin—pancreatic cancer	0.000164	0.00171	CcSEcCtD
Theophylline—Body temperature increased—Docetaxel—pancreatic cancer	0.000162	0.00168	CcSEcCtD
Theophylline—Abdominal pain—Docetaxel—pancreatic cancer	0.000162	0.00168	CcSEcCtD
Theophylline—Arrhythmia—Doxorubicin—pancreatic cancer	0.00016	0.00167	CcSEcCtD
Theophylline—Alopecia—Doxorubicin—pancreatic cancer	0.000159	0.00165	CcSEcCtD
Theophylline—Agitation—Epirubicin—pancreatic cancer	0.000155	0.00162	CcSEcCtD
Theophylline—Tension—Doxorubicin—pancreatic cancer	0.000153	0.0016	CcSEcCtD
Theophylline—Nervousness—Doxorubicin—pancreatic cancer	0.000152	0.00158	CcSEcCtD
Theophylline—Hypersensitivity—Docetaxel—pancreatic cancer	0.000151	0.00157	CcSEcCtD
Theophylline—Palpitations—Epirubicin—pancreatic cancer	0.000149	0.00156	CcSEcCtD
Theophylline—Convulsion—Epirubicin—pancreatic cancer	0.000146	0.00153	CcSEcCtD
Theophylline—Pruritus—Docetaxel—pancreatic cancer	0.000145	0.00151	CcSEcCtD
Theophylline—Agitation—Doxorubicin—pancreatic cancer	0.000144	0.0015	CcSEcCtD
Theophylline—Anxiety—Epirubicin—pancreatic cancer	0.000143	0.00149	CcSEcCtD
Theophylline—Diarrhoea—Docetaxel—pancreatic cancer	0.00014	0.00146	CcSEcCtD
Theophylline—Palpitations—Doxorubicin—pancreatic cancer	0.000138	0.00144	CcSEcCtD
Theophylline—Anaphylactic shock—Epirubicin—pancreatic cancer	0.000138	0.00144	CcSEcCtD
Theophylline—Infection—Epirubicin—pancreatic cancer	0.000137	0.00143	CcSEcCtD
Theophylline—Shock—Epirubicin—pancreatic cancer	0.000136	0.00141	CcSEcCtD
Theophylline—Convulsion—Doxorubicin—pancreatic cancer	0.000135	0.00141	CcSEcCtD
Theophylline—Nervous system disorder—Epirubicin—pancreatic cancer	0.000135	0.00141	CcSEcCtD
Theophylline—Dizziness—Docetaxel—pancreatic cancer	0.000135	0.00141	CcSEcCtD
Theophylline—Tachycardia—Epirubicin—pancreatic cancer	0.000134	0.0014	CcSEcCtD
Theophylline—Anxiety—Doxorubicin—pancreatic cancer	0.000133	0.00138	CcSEcCtD
Theophylline—Anorexia—Epirubicin—pancreatic cancer	0.000131	0.00137	CcSEcCtD
Theophylline—Vomiting—Docetaxel—pancreatic cancer	0.00013	0.00136	CcSEcCtD
Theophylline—Rash—Docetaxel—pancreatic cancer	0.000129	0.00134	CcSEcCtD
Theophylline—Hypotension—Epirubicin—pancreatic cancer	0.000129	0.00134	CcSEcCtD
Theophylline—Dermatitis—Docetaxel—pancreatic cancer	0.000129	0.00134	CcSEcCtD
Theophylline—Headache—Docetaxel—pancreatic cancer	0.000128	0.00134	CcSEcCtD
Theophylline—Anaphylactic shock—Doxorubicin—pancreatic cancer	0.000128	0.00133	CcSEcCtD
Theophylline—Infection—Doxorubicin—pancreatic cancer	0.000127	0.00132	CcSEcCtD
Theophylline—Shock—Doxorubicin—pancreatic cancer	0.000125	0.00131	CcSEcCtD
Theophylline—Nervous system disorder—Doxorubicin—pancreatic cancer	0.000125	0.0013	CcSEcCtD
Theophylline—Insomnia—Epirubicin—pancreatic cancer	0.000125	0.0013	CcSEcCtD
Theophylline—Tachycardia—Doxorubicin—pancreatic cancer	0.000124	0.0013	CcSEcCtD
Theophylline—Anorexia—Doxorubicin—pancreatic cancer	0.000122	0.00127	CcSEcCtD
Theophylline—Nausea—Docetaxel—pancreatic cancer	0.000121	0.00127	CcSEcCtD
Theophylline—Decreased appetite—Epirubicin—pancreatic cancer	0.00012	0.00125	CcSEcCtD
Theophylline—Hypotension—Doxorubicin—pancreatic cancer	0.000119	0.00124	CcSEcCtD
Theophylline—Insomnia—Doxorubicin—pancreatic cancer	0.000115	0.0012	CcSEcCtD
Theophylline—Gastrointestinal pain—Epirubicin—pancreatic cancer	0.000113	0.00118	CcSEcCtD
Theophylline—Decreased appetite—Doxorubicin—pancreatic cancer	0.000111	0.00116	CcSEcCtD
Theophylline—Urticaria—Epirubicin—pancreatic cancer	0.000109	0.00114	CcSEcCtD
Theophylline—Abdominal pain—Epirubicin—pancreatic cancer	0.000109	0.00114	CcSEcCtD
Theophylline—Body temperature increased—Epirubicin—pancreatic cancer	0.000109	0.00114	CcSEcCtD
Theophylline—Gastrointestinal pain—Doxorubicin—pancreatic cancer	0.000104	0.00109	CcSEcCtD
Theophylline—Hypersensitivity—Epirubicin—pancreatic cancer	0.000102	0.00106	CcSEcCtD
Theophylline—Urticaria—Doxorubicin—pancreatic cancer	0.000101	0.00106	CcSEcCtD
Theophylline—Body temperature increased—Doxorubicin—pancreatic cancer	0.000101	0.00105	CcSEcCtD
Theophylline—Abdominal pain—Doxorubicin—pancreatic cancer	0.000101	0.00105	CcSEcCtD
Theophylline—Pruritus—Epirubicin—pancreatic cancer	9.75e-05	0.00102	CcSEcCtD
Theophylline—Diarrhoea—Epirubicin—pancreatic cancer	9.43e-05	0.000984	CcSEcCtD
Theophylline—Hypersensitivity—Doxorubicin—pancreatic cancer	9.39e-05	0.00098	CcSEcCtD
Theophylline—Dizziness—Epirubicin—pancreatic cancer	9.11e-05	0.000951	CcSEcCtD
Theophylline—Pruritus—Doxorubicin—pancreatic cancer	9.02e-05	0.000941	CcSEcCtD
Theophylline—Vomiting—Epirubicin—pancreatic cancer	8.76e-05	0.000914	CcSEcCtD
Theophylline—Diarrhoea—Doxorubicin—pancreatic cancer	8.72e-05	0.00091	CcSEcCtD
Theophylline—Rash—Epirubicin—pancreatic cancer	8.69e-05	0.000906	CcSEcCtD
Theophylline—Dermatitis—Epirubicin—pancreatic cancer	8.68e-05	0.000906	CcSEcCtD
Theophylline—Headache—Epirubicin—pancreatic cancer	8.63e-05	0.000901	CcSEcCtD
Theophylline—Dizziness—Doxorubicin—pancreatic cancer	8.43e-05	0.00088	CcSEcCtD
Theophylline—Nausea—Epirubicin—pancreatic cancer	8.19e-05	0.000854	CcSEcCtD
Theophylline—Vomiting—Doxorubicin—pancreatic cancer	8.11e-05	0.000846	CcSEcCtD
Theophylline—Rash—Doxorubicin—pancreatic cancer	8.04e-05	0.000839	CcSEcCtD
Theophylline—Dermatitis—Doxorubicin—pancreatic cancer	8.03e-05	0.000838	CcSEcCtD
Theophylline—Headache—Doxorubicin—pancreatic cancer	7.99e-05	0.000833	CcSEcCtD
Theophylline—Nausea—Doxorubicin—pancreatic cancer	7.57e-05	0.00079	CcSEcCtD
Theophylline—PDE4B—Signaling Pathways—PTEN—pancreatic cancer	8.96e-06	5.5e-05	CbGpPWpGaD
Theophylline—CYP1B1—Metabolism—PIK3CG—pancreatic cancer	8.93e-06	5.49e-05	CbGpPWpGaD
Theophylline—HDAC2—Disease—MYC—pancreatic cancer	8.93e-06	5.49e-05	CbGpPWpGaD
Theophylline—HDAC2—Disease—TGFB1—pancreatic cancer	8.91e-06	5.48e-05	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	8.9e-06	5.47e-05	CbGpPWpGaD
Theophylline—CYP2C8—Metabolism—CD44—pancreatic cancer	8.86e-06	5.45e-05	CbGpPWpGaD
Theophylline—ADORA2B—Signaling Pathways—MYC—pancreatic cancer	8.86e-06	5.44e-05	CbGpPWpGaD
Theophylline—ADORA1—Signaling by GPCR—AKT1—pancreatic cancer	8.84e-06	5.43e-05	CbGpPWpGaD
Theophylline—ADORA2B—Signaling Pathways—TGFB1—pancreatic cancer	8.84e-06	5.43e-05	CbGpPWpGaD
Theophylline—PDE4A—Signaling Pathways—VEGFA—pancreatic cancer	8.74e-06	5.37e-05	CbGpPWpGaD
Theophylline—HDAC2—Disease—EGFR—pancreatic cancer	8.74e-06	5.37e-05	CbGpPWpGaD
Theophylline—PDE4B—Signaling by GPCR—AKT1—pancreatic cancer	8.74e-06	5.37e-05	CbGpPWpGaD
Theophylline—PDE3A—Signaling Pathways—SRC—pancreatic cancer	8.73e-06	5.37e-05	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	8.73e-06	5.36e-05	CbGpPWpGaD
Theophylline—CYP1A1—Metabolism—STK11—pancreatic cancer	8.71e-06	5.35e-05	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—PIK3CB—pancreatic cancer	8.71e-06	5.35e-05	CbGpPWpGaD
Theophylline—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	8.68e-06	5.33e-05	CbGpPWpGaD
Theophylline—ADORA2B—Signaling Pathways—EGFR—pancreatic cancer	8.66e-06	5.32e-05	CbGpPWpGaD
Theophylline—PDE4A—Signaling Pathways—STAT3—pancreatic cancer	8.66e-06	5.32e-05	CbGpPWpGaD
Theophylline—PDE4A—Signaling Pathways—NRAS—pancreatic cancer	8.64e-06	5.31e-05	CbGpPWpGaD
Theophylline—CYP1B1—Metabolism—PPARG—pancreatic cancer	8.62e-06	5.3e-05	CbGpPWpGaD
Theophylline—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	8.6e-06	5.28e-05	CbGpPWpGaD
Theophylline—PDE3B—Signaling Pathways—MYC—pancreatic cancer	8.59e-06	5.28e-05	CbGpPWpGaD
Theophylline—PDE3B—Signaling Pathways—TGFB1—pancreatic cancer	8.57e-06	5.27e-05	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—GLP1R—pancreatic cancer	8.53e-06	5.24e-05	CbGpPWpGaD
Theophylline—PDE3A—Signaling Pathways—VEGFA—pancreatic cancer	8.51e-06	5.23e-05	CbGpPWpGaD
Theophylline—CYP2C8—Metabolism—GCG—pancreatic cancer	8.5e-06	5.22e-05	CbGpPWpGaD
Theophylline—PDE4D—Signaling Pathways—MYC—pancreatic cancer	8.45e-06	5.19e-05	CbGpPWpGaD
Theophylline—PDE4D—Signaling Pathways—TGFB1—pancreatic cancer	8.43e-06	5.18e-05	CbGpPWpGaD
Theophylline—PDE3A—Signaling Pathways—STAT3—pancreatic cancer	8.42e-06	5.17e-05	CbGpPWpGaD
Theophylline—ADORA1—Signaling Pathways—SRC—pancreatic cancer	8.41e-06	5.17e-05	CbGpPWpGaD
Theophylline—PDE3B—Signaling Pathways—EGFR—pancreatic cancer	8.4e-06	5.16e-05	CbGpPWpGaD
Theophylline—PDE3A—Signaling Pathways—NRAS—pancreatic cancer	8.4e-06	5.16e-05	CbGpPWpGaD
Theophylline—ADA—Metabolism—AKT1—pancreatic cancer	8.4e-06	5.16e-05	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—DPYD—pancreatic cancer	8.39e-06	5.15e-05	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—CXCL8—pancreatic cancer	8.37e-06	5.14e-05	CbGpPWpGaD
Theophylline—ADORA2A—Signaling by GPCR—PIK3CA—pancreatic cancer	8.36e-06	5.14e-05	CbGpPWpGaD
Theophylline—PDE4B—Signaling Pathways—SRC—pancreatic cancer	8.31e-06	5.1e-05	CbGpPWpGaD
Theophylline—PDE4D—Signaling Pathways—EGFR—pancreatic cancer	8.27e-06	5.08e-05	CbGpPWpGaD
Theophylline—HDAC2—Disease—KRAS—pancreatic cancer	8.25e-06	5.07e-05	CbGpPWpGaD
Theophylline—PDE4C—Signaling Pathways—PIK3CA—pancreatic cancer	8.24e-06	5.06e-05	CbGpPWpGaD
Theophylline—ADORA1—Signaling Pathways—VEGFA—pancreatic cancer	8.19e-06	5.03e-05	CbGpPWpGaD
Theophylline—ADORA2B—Signaling Pathways—KRAS—pancreatic cancer	8.19e-06	5.03e-05	CbGpPWpGaD
Theophylline—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	8.18e-06	5.03e-05	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—TYMP—pancreatic cancer	8.16e-06	5.02e-05	CbGpPWpGaD
Theophylline—ADORA1—Signaling Pathways—STAT3—pancreatic cancer	8.11e-06	4.98e-05	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	8.1e-06	4.98e-05	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—PIK3CB—pancreatic cancer	8.1e-06	4.98e-05	CbGpPWpGaD
Theophylline—PDE4B—Signaling Pathways—VEGFA—pancreatic cancer	8.09e-06	4.97e-05	CbGpPWpGaD
Theophylline—ADORA1—Signaling Pathways—NRAS—pancreatic cancer	8.09e-06	4.97e-05	CbGpPWpGaD
Theophylline—PDE4A—Signaling Pathways—MYC—pancreatic cancer	8.04e-06	4.94e-05	CbGpPWpGaD
Theophylline—PDE4A—Signaling Pathways—TGFB1—pancreatic cancer	8.02e-06	4.93e-05	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—CASP3—pancreatic cancer	8.01e-06	4.92e-05	CbGpPWpGaD
Theophylline—PDE4B—Signaling Pathways—STAT3—pancreatic cancer	8.01e-06	4.92e-05	CbGpPWpGaD
Theophylline—PDE4B—Signaling Pathways—NRAS—pancreatic cancer	7.99e-06	4.91e-05	CbGpPWpGaD
Theophylline—CYP2C8—Metabolism—STK11—pancreatic cancer	7.99e-06	4.91e-05	CbGpPWpGaD
Theophylline—PDE4C—Signaling Pathways—TP53—pancreatic cancer	7.97e-06	4.9e-05	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—SLC2A2—pancreatic cancer	7.96e-06	4.89e-05	CbGpPWpGaD
Theophylline—CYP2E1—Metabolism—TYMS—pancreatic cancer	7.95e-06	4.89e-05	CbGpPWpGaD
Theophylline—PDE3B—Signaling Pathways—KRAS—pancreatic cancer	7.94e-06	4.88e-05	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	7.88e-06	4.84e-05	CbGpPWpGaD
Theophylline—PDE4A—Signaling Pathways—EGFR—pancreatic cancer	7.87e-06	4.83e-05	CbGpPWpGaD
Theophylline—CYP1B1—Metabolism—PIK3CD—pancreatic cancer	7.85e-06	4.83e-05	CbGpPWpGaD
Theophylline—PDE3A—Signaling Pathways—MYC—pancreatic cancer	7.83e-06	4.81e-05	CbGpPWpGaD
Theophylline—PDE4D—Signaling Pathways—KRAS—pancreatic cancer	7.81e-06	4.8e-05	CbGpPWpGaD
Theophylline—PDE3A—Signaling Pathways—TGFB1—pancreatic cancer	7.81e-06	4.8e-05	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—CCND1—pancreatic cancer	7.8e-06	4.79e-05	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—CXCL8—pancreatic cancer	7.78e-06	4.78e-05	CbGpPWpGaD
Theophylline—ADORA2A—Signaling by GPCR—HRAS—pancreatic cancer	7.73e-06	4.75e-05	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—CTNNB1—pancreatic cancer	7.72e-06	4.75e-05	CbGpPWpGaD
Theophylline—PDE3A—Signaling Pathways—EGFR—pancreatic cancer	7.65e-06	4.7e-05	CbGpPWpGaD
Theophylline—PDE4C—Signaling Pathways—HRAS—pancreatic cancer	7.62e-06	4.69e-05	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	7.6e-06	4.67e-05	CbGpPWpGaD
Theophylline—HDAC2—Disease—PIK3CA—pancreatic cancer	7.58e-06	4.66e-05	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—MMP9—pancreatic cancer	7.57e-06	4.65e-05	CbGpPWpGaD
Theophylline—ADORA1—Signaling Pathways—MYC—pancreatic cancer	7.53e-06	4.63e-05	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—PTEN—pancreatic cancer	7.53e-06	4.63e-05	CbGpPWpGaD
Theophylline—ADORA2B—Signaling Pathways—PIK3CA—pancreatic cancer	7.52e-06	4.62e-05	CbGpPWpGaD
Theophylline—ADORA2A—GPCR downstream signaling—AKT1—pancreatic cancer	7.52e-06	4.62e-05	CbGpPWpGaD
Theophylline—ADORA1—Signaling Pathways—TGFB1—pancreatic cancer	7.51e-06	4.62e-05	CbGpPWpGaD
Theophylline—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	7.5e-06	4.61e-05	CbGpPWpGaD
Theophylline—CYP1A1—Metabolism—TYMS—pancreatic cancer	7.5e-06	4.61e-05	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—CASP3—pancreatic cancer	7.45e-06	4.58e-05	CbGpPWpGaD
Theophylline—PDE4B—Signaling Pathways—MYC—pancreatic cancer	7.44e-06	4.57e-05	CbGpPWpGaD
Theophylline—PDE4A—Signaling Pathways—KRAS—pancreatic cancer	7.43e-06	4.57e-05	CbGpPWpGaD
Theophylline—PDE4B—Signaling Pathways—TGFB1—pancreatic cancer	7.43e-06	4.56e-05	CbGpPWpGaD
Theophylline—ADORA1—Signaling Pathways—EGFR—pancreatic cancer	7.37e-06	4.53e-05	CbGpPWpGaD
Theophylline—PDE3B—Signaling Pathways—PIK3CA—pancreatic cancer	7.29e-06	4.48e-05	CbGpPWpGaD
Theophylline—PDE4B—Signaling Pathways—EGFR—pancreatic cancer	7.28e-06	4.47e-05	CbGpPWpGaD
Theophylline—CYP2D6—Metabolism—CD44—pancreatic cancer	7.28e-06	4.47e-05	CbGpPWpGaD
Theophylline—ADORA2B—Signaling Pathways—TP53—pancreatic cancer	7.28e-06	4.47e-05	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—CCND1—pancreatic cancer	7.25e-06	4.46e-05	CbGpPWpGaD
Theophylline—PDE3A—Signaling Pathways—KRAS—pancreatic cancer	7.23e-06	4.44e-05	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism—CD44—pancreatic cancer	7.21e-06	4.43e-05	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—CTNNB1—pancreatic cancer	7.18e-06	4.41e-05	CbGpPWpGaD
Theophylline—PDE4D—Signaling Pathways—PIK3CA—pancreatic cancer	7.17e-06	4.41e-05	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	7.06e-06	4.34e-05	CbGpPWpGaD
Theophylline—PDE3B—Signaling Pathways—TP53—pancreatic cancer	7.06e-06	4.34e-05	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—MMP9—pancreatic cancer	7.04e-06	4.33e-05	CbGpPWpGaD
Theophylline—HDAC2—Disease—HRAS—pancreatic cancer	7.02e-06	4.31e-05	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	7e-06	4.3e-05	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—PTEN—pancreatic cancer	7e-06	4.3e-05	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—SRC—pancreatic cancer	6.98e-06	4.29e-05	CbGpPWpGaD
Theophylline—CYP2D6—Metabolism—GCG—pancreatic cancer	6.98e-06	4.29e-05	CbGpPWpGaD
Theophylline—ADORA1—Signaling Pathways—KRAS—pancreatic cancer	6.96e-06	4.28e-05	CbGpPWpGaD
Theophylline—ADORA2B—Signaling Pathways—HRAS—pancreatic cancer	6.96e-06	4.28e-05	CbGpPWpGaD
Theophylline—PDE4D—Signaling Pathways—TP53—pancreatic cancer	6.94e-06	4.26e-05	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	6.93e-06	4.26e-05	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism—GCG—pancreatic cancer	6.92e-06	4.25e-05	CbGpPWpGaD
Theophylline—PDE4B—Signaling Pathways—KRAS—pancreatic cancer	6.88e-06	4.23e-05	CbGpPWpGaD
Theophylline—CYP2C8—Metabolism—TYMS—pancreatic cancer	6.87e-06	4.22e-05	CbGpPWpGaD
Theophylline—CYP1B1—Metabolism—PIK3CB—pancreatic cancer	6.85e-06	4.21e-05	CbGpPWpGaD
Theophylline—PDE4A—Signaling Pathways—PIK3CA—pancreatic cancer	6.83e-06	4.2e-05	CbGpPWpGaD
Theophylline—ADORA2A—Signaling by GPCR—AKT1—pancreatic cancer	6.83e-06	4.2e-05	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—VEGFA—pancreatic cancer	6.8e-06	4.18e-05	CbGpPWpGaD
Theophylline—CYP1B1—Metabolism—PTGS2—pancreatic cancer	6.78e-06	4.17e-05	CbGpPWpGaD
Theophylline—PDE3B—Signaling Pathways—HRAS—pancreatic cancer	6.75e-06	4.15e-05	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—STAT3—pancreatic cancer	6.73e-06	4.14e-05	CbGpPWpGaD
Theophylline—PDE4C—Signaling Pathways—AKT1—pancreatic cancer	6.73e-06	4.14e-05	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—NRAS—pancreatic cancer	6.72e-06	4.13e-05	CbGpPWpGaD
Theophylline—HDAC2—Gene Expression—AKT1—pancreatic cancer	6.67e-06	4.1e-05	CbGpPWpGaD
Theophylline—PDE3A—Signaling Pathways—PIK3CA—pancreatic cancer	6.64e-06	4.08e-05	CbGpPWpGaD
Theophylline—PDE4D—Signaling Pathways—HRAS—pancreatic cancer	6.64e-06	4.08e-05	CbGpPWpGaD
Theophylline—PDE4A—Signaling Pathways—TP53—pancreatic cancer	6.61e-06	4.06e-05	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—GLP1R—pancreatic cancer	6.58e-06	4.04e-05	CbGpPWpGaD
Theophylline—CYP2D6—Metabolism—STK11—pancreatic cancer	6.56e-06	4.03e-05	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism—STK11—pancreatic cancer	6.5e-06	4e-05	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—SRC—pancreatic cancer	6.49e-06	3.99e-05	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—DPYD—pancreatic cancer	6.47e-06	3.98e-05	CbGpPWpGaD
Theophylline—CYP2E1—Metabolism—APOE—pancreatic cancer	6.47e-06	3.97e-05	CbGpPWpGaD
Theophylline—PDE3A—Signaling Pathways—TP53—pancreatic cancer	6.43e-06	3.95e-05	CbGpPWpGaD
Theophylline—ADORA1—Signaling Pathways—PIK3CA—pancreatic cancer	6.39e-06	3.93e-05	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—VEGFA—pancreatic cancer	6.32e-06	3.88e-05	CbGpPWpGaD
Theophylline—PDE4B—Signaling Pathways—PIK3CA—pancreatic cancer	6.32e-06	3.88e-05	CbGpPWpGaD
Theophylline—PDE4A—Signaling Pathways—HRAS—pancreatic cancer	6.32e-06	3.88e-05	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—STAT3—pancreatic cancer	6.26e-06	3.85e-05	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—MYC—pancreatic cancer	6.26e-06	3.84e-05	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—NRAS—pancreatic cancer	6.24e-06	3.84e-05	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—TGFB1—pancreatic cancer	6.24e-06	3.83e-05	CbGpPWpGaD
Theophylline—HDAC2—Disease—AKT1—pancreatic cancer	6.2e-06	3.81e-05	CbGpPWpGaD
Theophylline—ADORA1—Signaling Pathways—TP53—pancreatic cancer	6.19e-06	3.8e-05	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—CD44—pancreatic cancer	6.16e-06	3.79e-05	CbGpPWpGaD
Theophylline—PDE3A—Signaling Pathways—HRAS—pancreatic cancer	6.15e-06	3.78e-05	CbGpPWpGaD
Theophylline—ADORA2B—Signaling Pathways—AKT1—pancreatic cancer	6.14e-06	3.78e-05	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—SLC2A2—pancreatic cancer	6.14e-06	3.77e-05	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—EGFR—pancreatic cancer	6.12e-06	3.76e-05	CbGpPWpGaD
Theophylline—PDE4B—Signaling Pathways—TP53—pancreatic cancer	6.11e-06	3.76e-05	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	6.1e-06	3.75e-05	CbGpPWpGaD
Theophylline—CYP1A1—Metabolism—APOE—pancreatic cancer	6.1e-06	3.75e-05	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	6.04e-06	3.71e-05	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	5.98e-06	3.68e-05	CbGpPWpGaD
Theophylline—PDE3B—Signaling Pathways—AKT1—pancreatic cancer	5.96e-06	3.66e-05	CbGpPWpGaD
Theophylline—ADORA1—Signaling Pathways—HRAS—pancreatic cancer	5.92e-06	3.64e-05	CbGpPWpGaD
Theophylline—CYP1B1—Metabolism—PTEN—pancreatic cancer	5.92e-06	3.63e-05	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—GCG—pancreatic cancer	5.91e-06	3.63e-05	CbGpPWpGaD
Theophylline—PDE4D—Signaling Pathways—AKT1—pancreatic cancer	5.86e-06	3.6e-05	CbGpPWpGaD
Theophylline—PDE4B—Signaling Pathways—HRAS—pancreatic cancer	5.85e-06	3.59e-05	CbGpPWpGaD
Theophylline—CYP2E1—Metabolism—PIK3CG—pancreatic cancer	5.84e-06	3.59e-05	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—MYC—pancreatic cancer	5.82e-06	3.57e-05	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—TGFB1—pancreatic cancer	5.8e-06	3.56e-05	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—KRAS—pancreatic cancer	5.78e-06	3.55e-05	CbGpPWpGaD
Theophylline—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	5.77e-06	3.55e-05	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—EGFR—pancreatic cancer	5.69e-06	3.5e-05	CbGpPWpGaD
Theophylline—CYP2D6—Metabolism—TYMS—pancreatic cancer	5.64e-06	3.47e-05	CbGpPWpGaD
Theophylline—CYP2E1—Metabolism—PPARG—pancreatic cancer	5.63e-06	3.46e-05	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism—TYMS—pancreatic cancer	5.59e-06	3.44e-05	CbGpPWpGaD
Theophylline—CYP2C8—Metabolism—APOE—pancreatic cancer	5.59e-06	3.43e-05	CbGpPWpGaD
Theophylline—PDE4A—Signaling Pathways—AKT1—pancreatic cancer	5.58e-06	3.43e-05	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—STK11—pancreatic cancer	5.56e-06	3.41e-05	CbGpPWpGaD
Theophylline—CYP1A1—Metabolism—PIK3CG—pancreatic cancer	5.5e-06	3.38e-05	CbGpPWpGaD
Theophylline—PDE3A—Signaling Pathways—AKT1—pancreatic cancer	5.43e-06	3.33e-05	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—KRAS—pancreatic cancer	5.37e-06	3.3e-05	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—PIK3CA—pancreatic cancer	5.31e-06	3.26e-05	CbGpPWpGaD
Theophylline—CYP1A1—Metabolism—PPARG—pancreatic cancer	5.31e-06	3.26e-05	CbGpPWpGaD
Theophylline—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	5.29e-06	3.25e-05	CbGpPWpGaD
Theophylline—ADORA1—Signaling Pathways—AKT1—pancreatic cancer	5.22e-06	3.21e-05	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	5.22e-06	3.2e-05	CbGpPWpGaD
Theophylline—PDE4B—Signaling Pathways—AKT1—pancreatic cancer	5.16e-06	3.17e-05	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—TP53—pancreatic cancer	5.14e-06	3.16e-05	CbGpPWpGaD
Theophylline—CYP2E1—Metabolism—PIK3CD—pancreatic cancer	5.13e-06	3.15e-05	CbGpPWpGaD
Theophylline—CYP2C8—Metabolism—PIK3CG—pancreatic cancer	5.04e-06	3.1e-05	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—PIK3CA—pancreatic cancer	4.94e-06	3.03e-05	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—HRAS—pancreatic cancer	4.91e-06	3.02e-05	CbGpPWpGaD
Theophylline—CYP2C8—Metabolism—PPARG—pancreatic cancer	4.87e-06	2.99e-05	CbGpPWpGaD
Theophylline—CYP1A1—Metabolism—PIK3CD—pancreatic cancer	4.84e-06	2.97e-05	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—TYMS—pancreatic cancer	4.78e-06	2.94e-05	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—TP53—pancreatic cancer	4.78e-06	2.93e-05	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—CD44—pancreatic cancer	4.76e-06	2.92e-05	CbGpPWpGaD
Theophylline—CYP2D6—Metabolism—APOE—pancreatic cancer	4.59e-06	2.82e-05	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—HRAS—pancreatic cancer	4.57e-06	2.81e-05	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—GCG—pancreatic cancer	4.56e-06	2.8e-05	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism—APOE—pancreatic cancer	4.55e-06	2.8e-05	CbGpPWpGaD
Theophylline—CYP2E1—Metabolism—PIK3CB—pancreatic cancer	4.47e-06	2.75e-05	CbGpPWpGaD
Theophylline—CYP2C8—Metabolism—PIK3CD—pancreatic cancer	4.43e-06	2.72e-05	CbGpPWpGaD
Theophylline—CYP2E1—Metabolism—PTGS2—pancreatic cancer	4.43e-06	2.72e-05	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—AKT1—pancreatic cancer	4.34e-06	2.67e-05	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	4.31e-06	2.65e-05	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—STK11—pancreatic cancer	4.29e-06	2.64e-05	CbGpPWpGaD
Theophylline—CYP1A1—Metabolism—PIK3CB—pancreatic cancer	4.22e-06	2.59e-05	CbGpPWpGaD
Theophylline—CYP1A1—Metabolism—PTGS2—pancreatic cancer	4.18e-06	2.57e-05	CbGpPWpGaD
Theophylline—CYP1B1—Metabolism—PIK3CA—pancreatic cancer	4.17e-06	2.56e-05	CbGpPWpGaD
Theophylline—CYP2D6—Metabolism—PIK3CG—pancreatic cancer	4.14e-06	2.54e-05	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism—PIK3CG—pancreatic cancer	4.11e-06	2.52e-05	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—AKT1—pancreatic cancer	4.03e-06	2.48e-05	CbGpPWpGaD
Theophylline—CYP2D6—Metabolism—PPARG—pancreatic cancer	4e-06	2.46e-05	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism—PPARG—pancreatic cancer	3.96e-06	2.43e-05	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—APOE—pancreatic cancer	3.89e-06	2.39e-05	CbGpPWpGaD
Theophylline—CYP2C8—Metabolism—PIK3CB—pancreatic cancer	3.87e-06	2.38e-05	CbGpPWpGaD
Theophylline—CYP2E1—Metabolism—PTEN—pancreatic cancer	3.86e-06	2.37e-05	CbGpPWpGaD
Theophylline—CYP2C8—Metabolism—PTGS2—pancreatic cancer	3.83e-06	2.35e-05	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—TYMS—pancreatic cancer	3.69e-06	2.27e-05	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	3.68e-06	2.26e-05	CbGpPWpGaD
Theophylline—CYP1A1—Metabolism—PTEN—pancreatic cancer	3.64e-06	2.24e-05	CbGpPWpGaD
Theophylline—CYP2D6—Metabolism—PIK3CD—pancreatic cancer	3.64e-06	2.24e-05	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism—PIK3CD—pancreatic cancer	3.61e-06	2.22e-05	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—PIK3CG—pancreatic cancer	3.51e-06	2.16e-05	CbGpPWpGaD
Theophylline—CYP1B1—Metabolism—AKT1—pancreatic cancer	3.41e-06	2.09e-05	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—PPARG—pancreatic cancer	3.39e-06	2.08e-05	CbGpPWpGaD
Theophylline—CYP2C8—Metabolism—PTEN—pancreatic cancer	3.34e-06	2.05e-05	CbGpPWpGaD
Theophylline—CYP2D6—Metabolism—PIK3CB—pancreatic cancer	3.17e-06	1.95e-05	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism—PIK3CB—pancreatic cancer	3.15e-06	1.93e-05	CbGpPWpGaD
Theophylline—CYP2D6—Metabolism—PTGS2—pancreatic cancer	3.14e-06	1.93e-05	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism—PTGS2—pancreatic cancer	3.12e-06	1.92e-05	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—PIK3CD—pancreatic cancer	3.08e-06	1.9e-05	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—APOE—pancreatic cancer	3e-06	1.84e-05	CbGpPWpGaD
Theophylline—CYP2D6—Metabolism—PTEN—pancreatic cancer	2.74e-06	1.68e-05	CbGpPWpGaD
Theophylline—CYP2E1—Metabolism—PIK3CA—pancreatic cancer	2.73e-06	1.68e-05	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism—PTEN—pancreatic cancer	2.72e-06	1.67e-05	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—PIK3CG—pancreatic cancer	2.71e-06	1.66e-05	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—PIK3CB—pancreatic cancer	2.69e-06	1.65e-05	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—PTGS2—pancreatic cancer	2.66e-06	1.64e-05	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—PPARG—pancreatic cancer	2.61e-06	1.61e-05	CbGpPWpGaD
Theophylline—CYP1A1—Metabolism—PIK3CA—pancreatic cancer	2.57e-06	1.58e-05	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—PIK3CD—pancreatic cancer	2.38e-06	1.46e-05	CbGpPWpGaD
Theophylline—CYP2C8—Metabolism—PIK3CA—pancreatic cancer	2.36e-06	1.45e-05	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—PTEN—pancreatic cancer	2.32e-06	1.43e-05	CbGpPWpGaD
Theophylline—CYP2E1—Metabolism—AKT1—pancreatic cancer	2.23e-06	1.37e-05	CbGpPWpGaD
Theophylline—CYP1A1—Metabolism—AKT1—pancreatic cancer	2.1e-06	1.29e-05	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—PIK3CB—pancreatic cancer	2.07e-06	1.27e-05	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—PTGS2—pancreatic cancer	2.06e-06	1.26e-05	CbGpPWpGaD
Theophylline—CYP2D6—Metabolism—PIK3CA—pancreatic cancer	1.93e-06	1.19e-05	CbGpPWpGaD
Theophylline—CYP2C8—Metabolism—AKT1—pancreatic cancer	1.92e-06	1.18e-05	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism—PIK3CA—pancreatic cancer	1.92e-06	1.18e-05	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—PTEN—pancreatic cancer	1.79e-06	1.1e-05	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—PIK3CA—pancreatic cancer	1.64e-06	1.01e-05	CbGpPWpGaD
Theophylline—CYP2D6—Metabolism—AKT1—pancreatic cancer	1.58e-06	9.71e-06	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism—AKT1—pancreatic cancer	1.57e-06	9.63e-06	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—AKT1—pancreatic cancer	1.34e-06	8.23e-06	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—PIK3CA—pancreatic cancer	1.26e-06	7.77e-06	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—AKT1—pancreatic cancer	1.03e-06	6.35e-06	CbGpPWpGaD
